Abstract
Best vitelliform macular dystrophy (BVMD) is caused by BEST1 mutation and leads to the accumulation of vitelliform material in the subretinal space. The formation of subretinal neovascular membrane can be one of BVMD complications. Herein, we discuss the criteria for initiating anti-VEGF therapy and efficacy assessment in two patients (3 eyes) with vitelliform macular dystrophy. Keyword: macular neovascularization, vitelliform macular dystrophy, optical coherence tomography, anti-VEGF therapy
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
